Stanford and BIO Announce New SPARK Showcase Event at 14th Annual BIO Investor Forum

Oct 6 2015
The Stanford University School of Medicine and BIO announce a new program – the SPARK Showcase Event – to feature the latest academic research for venture capital firms and business development executives seeking opportunities to expand their pipelines. The symposium will feature a keynote speech by Dr. Daria Mochly-Rosen, SPARK Director and George D. Smith Professor in Translational Medicine, Stanford University School of Medicine.

BIO Statement on Data Exclusivity Provisions Within the Trans-Pacific Partnership

Oct 4 2015


BIO Announces Complete Program Lineup for 14th Annual BIO Investor Forum

Sep 29 2015
BIO announces the final program and speakers for the 14th Annual BIO Investor Forum, an international investor forum which explores investment trends and opportunities in life sciences.  The event focuses on early and mid-stage private as well as emerging public companies that are poised for growth in 2016. The event will take place October 20-21, 2015, at the Parc 55 in San Francisco, California.

BIO Statement Concerning the Recent Ruling Issued by the PTO’s Patent Trial and Appeal Board

Sep 28 2015
"It is disappointing that the PTO’s Patent Trial and Appeal Board (PTAB) failed to properly assess the important issues raised by this motion. This cursory and erroneous ruling reinforces the immediate need for Congress and the PTO leadership to take clear and decisive action to prevent any further misuse and abuse of the Inter Partes Review process by hedge funds, extortionists and other questionable entities seeking to undermine it for their own financial benefit." 

Clinton Campaign Proposal Would Hamper Patient Access To Innovative New Cures and Therapies

Sep 22 2015
“The proposal released today by the Clinton campaign would do irreparable harm to the nation’s health innovation system, significantly hindering the ability of emerging biotechnology companies to develop the new cures and therapies that patients need to live longer, more productive lives...

BIO Issues 2016 BIO International Convention Call for Sessions & Speakers

Sep 17 2015
BIO calls on biopharmaceutical, business development, life sciences and policy experts to submit thought-provoking and timely proposals for sessions and speakers at the 2016 BIO International Convention. BIO 2016 will be held June 6-9, 2016 in San Francisco, California.

BIO Statement on Nomination of Dr. Robert Califf as FDA Commissioner

Sep 16 2015
BIO President and CEO Jim Greenwood released the following statement today commending President Barack Obama for his nomination of Dr. Robert Califf as Commissioner of the Food and Drug Administration (FDA):

2015 BIO Investor Forum Buzz of BIO Winners Announced

Sep 9 2015
BIO is pleased to announce the winners of the 2015 BIO Investor Forum Buzz of BIO contest, which recognizes highly innovative companies in the biotech sector. The Buzz of BIO at the BIO Investor Forum competition featured 19 nominees pulling in over 3,000 votes. The winners are...

BIO Announces San Diego to Host the World’s Largest Industrial Biotechnology Conference in 2016

Sep 8 2015
BIO officially announced that the 2016 World Congress on Industrial Biotechnology will be held April 17-20, 2016 in San Diego, California at the San Diego Convention Center. BIO is also announcing the call for papers for the event. Leaders from the biotechnology, bioenergy, chemical, consumer products manufacturing, and agricultural industries as well as academia and financial sectors are invited to submit proposals and individual papers beginning September 17, 2015.

Kyle Bass Continues Abuse of Patent Challenge System

Sep 3 2015
The Biotechnology Industry Organization (BIO) today released the following statement regarding the recent IPR challenges filed by hedge fund manager Kyle Bass.